The association of XRCC1 gene single nucleotide polymorphisms with response to neoadjuvant chemotherapy in locally advanced cervical carcinoma

<p>Abstract</p> <p>Background</p> <p>Platinum-based neoadjuvant chemotherapy (NAC) is new therapeutic strategy for locally advanced cervical carcinoma, but the variables used to predict NAC response are still infrequently reported. The aim of our study was to investigate the association between <it>XRCC1 </it>gene single nucleotide polymorphisms (SNPs) and NAC response.</p> <p>Methods</p> <p>Seventy patients with locally advanced cervical carcinoma who underwent NAC were collected. SNPs of <it>XRCC1 </it>(at codon 194 and 399) and XRCC1 protein expression were detected. The association of <it>XRCC1 </it>gene SNPs and protein expression with NAC response were analyzed.</p> <p>Results</p> <p>Response to NAC was not statistically significant in three genotypes, Arg/Arg, Arg/Trp, Trp/Trp of <it>XRCC1 </it>at codon 194(X²= 1.243, P = 0.07), while responses were significantly different in genotypes Arg/Arg, Arg/Gln, Gln/Gln of <it>XRCC1 </it>at codon 399 (X²= 2.283, P = 0.020). The risk of failure to chemotherapy in the patients with a Gln allele(Arg/Gln+Gln/Gln) was significantly greater than that with Arg/Arg(OR = 3.254, 95%CI 1.708 ~ 14.951). The expression level of XRCC1 protein was significantly associated with response to NAC. Moreover, the genotype with the Gln allele(Arg/Gln+Gln/Gln) at codon 399, but not codon at 194, presented a significantly higher level of XRCC1 protein expression than that with Arg/Arg genotype (F = 2.699, p = 0.009).</p> <p>Conclusion</p> <p>SNP of <it>XRCC1 </it>gene at codon 399 influences the response of cervical carcinoma to platinum-based NAC. This is probably due to changes in expression of XRCC1 protein, affecting response to chemotherapy.</p

4-Hydr­oxy-2,2,6,6-tetra­methyl­piperidinium hydrogensulfate monohydrate

In the title compound, C9H20NO+·HO4S−·H2O, the piperi­dinium ring adopts a chair conformation. Inter­molecular O—H⋯O and N—H⋯O hydrogen bonds form an extensive three-dimensional network, which consolidates the crystal structure

Using combination of lifting wavelet and multiclass SVM based on global optimization class strategy for fault pattern identification

This paper presents a new method based on lifting wavelet for obtaining a fast multiclass SVM classification based on global optimization class strategy for fault diagnosis of roller bearing. Decision making was performed in two stages: feature extraction by computing the lifting wavelet coefficients and classification using the multiclass SVM classifiers trained on the extracted features. Experiments demonstrate that in comparison to discrete wavelet transform the lifting wavelet feature extraction can speed up the identification phase as well as achieve higher accuracy of multiclass SVM that is based on global optimization class strategy. Experimental results also reveal that the proposed multiclass SVM of global optimization is better than strategy of one against one and DAGSVM

Sulfadiazine Sodium Ameliorates the Metabolomic Perturbation in Mice Infected with Toxoplasma gondii

In this study, we analyzed the global metabolomic changes associated with Toxoplasma gondii infection in mice in the presence or absence of sulfadiazine sodium (SDZ) treatment. BALB/c mice were infected with T. gondii GT1 strain and treated orally with SDZ (250 g/ml in water) for 12 consecutive days. Mice showed typical manifestations of illness at 20 days postinfection (dpi); by 30 dpi, 20% had survived and developed latent infection. We used ultraperformance liquid chromatography-mass spectrometry to profile the serum metabolomes in control (untreated and uninfected) mice, acutely infected mice, and SDZ-treated and infected mice. Infection induced significant perturbations in the metabolism of-linolenic acid, purine, pyrimidine, arginine, tryptophan, valine, glycerophospholipids, and fatty acyls. However, treatment with SDZ seemed to alleviate the serum metabolic alterations caused by infection. The restoration of the serum metabolite levels in the treated mice was associated with better clinical outcomes. These data indicate that untargeted metabolomics can reveal biochemical pathways associated with restoration of the metabolic status of T. gondii-infected mice following SDZ treatment and could be used to monitor responses to SDZ treatment. This study provides a new systems approach to elucidate the metabolic and therapeutic effects of SDZ in the context of murine toxoplasmosis. K E Y W O R D S Toxoplasma gondii, biomarkers, metabolomics, mice, serum metabolites, sulfadiazine sodium Toxoplasma gondii, an obligate intracellular protozoan parasite, is highly prevalent in warm-blooded animals and humans (1). T. gondii comprises three clonal lineages (type I, type II, and type III) (2). Despite 98% genetic similarity, dramatic differences in virulence exist among strains belonging to these T. gondii genotypes (3). Humans acquire infection mainly by ingesting undercooked meat containing tissue cysts or oocysts from contaminated water (4). Acute infection with this parasite is mediated by the aggressive, fast-replicating, tachyzoite stage, which can cause encephalitis or retinochoroiditis. In addition, reactivation of the latent form (i.e., bradyzoites-containing cysts) of T. gondii can cause life-threatening conditions and even death in immuno-compromised individuals (5)